Michael Schmidt
Stock Analyst at Guggenheim
Total Price Targets
13
Stocks Covered
11
Sectors
Healthcare
Most Recent
Jan 20, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Michael Schmidt
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $10.00 | $4.16 | +140.7% | 1 | Jan 20, 2026 |
| ADCT | ADC Therapeutics S.A. | $10.00 | $3.82 | +161.8% | 1 | Nov 12, 2025 |
| TNGX | Tango Therapeutics, Inc. | $12.00 | $20.95 | -42.7% | 1 | Oct 24, 2025 |
| KYMR | Kymera Therapeutics, Inc. | $60.00 | $81.54 | -26.4% | 1 | Jun 3, 2025 |
| EXEL | Exelixis, Inc. | $45.00 | $43.81 | +2.7% | 3 | May 15, 2025 |
| ERAS | Erasca, Inc. | $3.00 | $10.13 | -70.4% | 1 | May 14, 2025 |
| VSTM | Verastem, Inc. | $14.00 | $5.86 | +138.9% | 1 | Mar 24, 2025 |
| RVMD | Revolution Medicines, Inc. | $82.00 | $140.52 | -41.6% | 1 | Oct 28, 2024 |
| IMNM | Immunome, Inc. | $35.00 | $22.80 | +53.5% | 1 | Apr 15, 2024 |
| INCY | Incyte Corporation | $104.00 | $96.41 | +7.9% | 1 | Jan 3, 2022 |
| ALLO | Allogene Therapeutics, Inc. | $35.00 | $2.15 | +1531.7% | 1 | Jan 3, 2022 |
Recent Activity
- Jan 20, 2026— Set$10.00price target onCTMX(CytomX Therapeutics, Inc.)
- Nov 12, 2025— Set$10.00price target onADCT(ADC Therapeutics S.A.)
- Oct 24, 2025— Set$12.00price target onTNGX(Tango Therapeutics, Inc.)
- Jun 3, 2025— Set$60.00price target onKYMR(Kymera Therapeutics, Inc.)
- May 15, 2025— Set$45.00price target onEXEL(Exelixis, Inc.)
- May 14, 2025— Set$3.00price target onERAS(Erasca, Inc.)
- Mar 24, 2025— Set$14.00price target onVSTM(Verastem, Inc.)
- Jan 7, 2025— Set$42.00price target onEXEL(Exelixis, Inc.)
- Oct 28, 2024— Set$82.00price target onRVMD(Revolution Medicines, Inc.)
- Apr 15, 2024— Set$35.00price target onIMNM(Immunome, Inc.)
- Jan 3, 2022— Set$104.00price target onINCY(Incyte Corporation)
- Jan 3, 2022— Set$35.00price target onALLO(Allogene Therapeutics, Inc.)
- Jun 28, 2021— Set$30.00price target onEXEL(Exelixis, Inc.)
Frequently Asked Questions
Who is Michael Schmidt?
Michael Schmidt is a stock analyst at Guggenheim covering 11 stocks primarily in Healthcare. They have issued 13 price targets since Jun 28, 2021.
What stocks does Michael Schmidt cover?
Michael Schmidt currently covers 11 stocks, including EXEL, CTMX, ADCT, TNGX, KYMR.
What is Michael Schmidt's latest price target?
Michael Schmidt's most recent price target was $10.00 on CTMX (CytomX Therapeutics, Inc.), set on Jan 20, 2026.
What is Michael Schmidt's highest price target?
Michael Schmidt's highest issued price target is $104.00 on INCY, set on Jan 3, 2022.
More Analysts at Guggenheim
Coverage based on publicly published price targets. Not investment advice.